Indivior (LON:INDV) Trading 11.9% Higher - What's Next?

Indivior PLC (LON:INDV - Get Free Report) was up 11.9% during trading on Thursday . The stock traded as high as GBX 738 ($9.58) and last traded at GBX 731 ($9.49). Approximately 231,070 shares changed hands during trading, a decline of 82% from the average daily volume of 1,264,178 shares. The stock had previously closed at GBX 653.50 ($8.48).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 1,500 ($19.48) price target on shares of Indivior in a research note on Thursday, September 5th.

Indivior Price Performance

The stock has a market capitalization of £888.56 million, a P/E ratio of -863.75, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of 2,790.00, a current ratio of 0.85 and a quick ratio of 1.52. The company's 50-day simple moving average is GBX 774.08 and its 200-day simple moving average is GBX 1,087.15.

Insider Activity

In other Indivior news, insider Jo Le Couilliard acquired 1,490 shares of the business's stock in a transaction dated Friday, July 26th. The stock was bought at an average cost of GBX 1,006 ($13.06) per share, with a total value of £14,989.40 ($19,461.70). 3.44% of the stock is owned by insiders.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.